Multiple myeloma and its interaction with the tumour microenvironment are currently at the centre of rapid medical advancements. Unravelling the complex biology of plasma cells and their interaction with the surrounding tissue is crucial to better understanding the development of the disease and opening up innovative treatment pathways. The aim of current research is to identify new therapeutic targets through precise analyses of cellular pathways and to improve the chances of recovery in the long term.
To mark our 50th anniversary, the Wilhelm Sander Foundation is supporting the 7th Würzburg Myeloma Workshop as a sponsoring partner. This important symposium serves as an international forum to bring together leading experts from around the world and discuss the latest breakthroughs in haematology at the highest level.
Under the scientific leadership of Professor Hermann Einsele and his team, the event offers an opportunity to present the latest advances in CAR-T cell therapies, bispecific antibodies and personalised treatment approaches. The focus is on direct dialogue between cutting-edge international research and clinical application. We look forward to two days full of groundbreaking insights and an intensive exchange of knowledge in Würzburg.
Highlights from the symposium
